Argentina Generic Drugs Market by Type (Small Molecule, Biosimilars), By Mode of Drug Delivery (Oral, Topical, Parenteral, and Others), By Form (Tablet, Capsule, Injection, and Others), By Source (In House, Contract Manufacturing Organizations), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), By Application (Cardiovascular Disease, Diabetes, Neurology, Onco
Published Date: November - 2024 | Publisher: MIR | No of Pages: 320 | Industry: Healthcare | Format: Report available in PDF / Excel Format
View Details Buy Now 2890 Download Sample Ask for Discount Request CustomizationArgentina Generic Drugs Market by Type (Small Molecule, Biosimilars), By Mode of Drug Delivery (Oral, Topical, Parenteral, and Others), By Form (Tablet, Capsule, Injection, and Others), By Source (In House, Contract Manufacturing Organizations), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), By Application (Cardiovascular Disease, Diabetes, Neurology, Onco
Argentina has about 65 biotech businesses focused on human health, with a focus on generics and biosimilars. More than a dozen of these firm’s exports biosimilars, especially to other countries in the region and Asia. Between 2003 and 2017, sales to China, India, and Vietnam climbed by 179%.
Cost Saving Promises To Drive The Market
According to stats of IMS health, the price of some generic medicine of 10 mg x 30 Pack is USD509 and the price of branded medicine of same pack is USD3200 which is 84.09% high than generic medications.
Patent Expirations Expected to Drive the Market
There are no provisions for patent term extensions; patents are granted for 20 years from the date of filing. There is no case law on this subject, and the patent law does not expressly provide for provisional protection of a patent application prior to issuance
Increase In Geriatric Population
According to IMS Health, the increase in the demand for generic medicines in recent years is 8.2% which is further expected to grow.
Recent Developments
A Brazilian pharmaceutical company, Eurofarma, acquired one of Argentina’s top generic drug manufacturers at the end of 2020. The acquisition is expected to boost Eurofarma’s position in Argentina and broaden its product range.
In 2021, the merger between Elea Laboratories and Savant Pharm merger was announced, which created a new entity called ELSA. It is expected to become one of the largest pharmaceutical companies in Argentina. The merger is expected to bring together the strengths of both companies in research and development, manufacturing, and commercialization.
In 2020, the Argentine generic drug manufacturer, Richmond, signed a licensing agreement with the Russian Direct Investment Fund to produce and market the COVID-19 vaccine Sputnik V in Argentina.
Market Segmentation
The Argentina generic drugs market can be segmented by type, mode of drug delivery, form, source, distribution channel, application, and region. Based on type, the market can be segmented into small molecules and biosimilars. Based on mode of drug delivery, the market is segmented into oral, topical, parenteral, and others. Based on form, the market can be segmented into tablets, capsule, injection, and others. Based on source, the market can be segmented into in house and contract manufacturing organizations. Based on distribution channel, the market can be grouped into hospital pharmacies, retail pharmacies, and online pharmacies. Based on application, the market can be grouped into cardiovascular diseases, diabetes, neurology, oncology, anti-inflammatory diseases, and others.
Market Players
Laboratories Bagó S.A, Laboratorios Richmond, Gador S.A., Elea Laboratories Srl, Laboratorios Phoenix SE, Raffo Laboratories Ltd., Craveri S.A., Sidus S.A/Argentina. are some of the leading players operating in the Argentina generic drugs market.
| Attribute | Details |
| Base Year | 2022 |
| Historic Data | 2018 – 2021 |
| Estimated Year | 2023 |
| Forecast Period | 2024 – 2028 |
| Quantitative Units | Revenue in USD Million, and CAGR for 2018-2022 and 2023-2028 |
| Report Coverage | Revenue forecast, company share, competitive landscape, growth factors, and trends |
| Segments Covered | Type Mode of Drug Delivery Form Source Distribution Channel Application |
| Regional scope | Pampas, Litoral, Northwest, Sierras, and Cuyo |
| Key companies profiled | Laboratories Bagó S.A, Laboratorios Richmond, Gador S.A., Elea Laboratories Srl, Laboratorios Phoenix SE, Raffo Laboratories Ltd., Craveri S.A., Sidus S.A/Argentina. |
| Customization scope | 10% free report customization with purchase. Addition or alteration to country, regional & segment scope. |
| Pricing and purchase options | Avail customized purchase options to meet your exact research needs. Explore purchase options |
| Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
FAQ'S
For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:
Within 24 to 48 hrs.
You can contact Sales team (sales@marketinsightsresearch.com) and they will direct you on email
You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.
Discounts are available.
Hard Copy